Sections
Studies
- Alzheimer’s Ups Seizure Risk
- Why Knee Replacements Fail
- Thinks It’s PTSD? Look At the Age.
- On Statins? Good Cholesterol May Not Matter.
- Some Sugars Aid Cancer Growth
- Workplace Stress Puts Heart at Risk
- Exercise, Weight Control Fibromyalgia
- Stent Implants Up Post-Surgical Risk
- Lack of Sleep Raises Insulin Resistance
- Chronic Pain May Have Genetic Root
Trends
- Hospital Checklist Part 2: Communication, Cultural Competency and Patient-Centered Care
- New Cultures of Health: Driving Value for Employers, Hospitals and Others
- Emerging Models: The ABCs of ACOs
- Vanderbilt Launches Personalized Cancer Center
- 1 of 8 ED Visits Caused by Mental Health, Substance Abuse
- New Tool Compares Healthcare Services
- Hospitalists Miss Mark on Costs
- Hospital Checklist: Communication, Cultural Competency and Patient-Centered Care
- Medical Necessity Becomes Clear: 18 Reviews To Date
- How To Implement Motivational Interviewing
Home 
Industry News Studies Stroke Medication Vital for Women
Industry News Studies Stroke Medication Vital for Women
| Stroke Medication Vital for Women |
 |
 |
 |
| Wednesday, 14 April 2010 12:59 |
|
|
A clot-eradicating drug is vital to the health of women who have suffered stroke, according to a study from the American Academy of Neurology. Analyzing stroke patients who were administered tissue plasminogen activator (tPA) and those who were not, researchers found that women fared worse than men when not given the drug. When administered tPA, both populations tended to see similar outcomes. However, when tPA was not present, 12 percent fewer women saw positive outcomes than men six months after a stroke.